Nippon Life Global Investors Americas Inc. Buys 9,870 Shares of Monsanto Company (MON)

Nippon Life Global Investors Americas Inc. increased its stake in shares of Monsanto Company (NYSE:MON) by 14.7% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 76,970 shares of the basic materials company’s stock after purchasing an additional 9,870 shares during the period. Nippon Life Global Investors Americas Inc.’s holdings in Monsanto were worth $9,224,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Meyer Handelman Co. increased its stake in Monsanto by 0.6% in the 3rd quarter. Meyer Handelman Co. now owns 124,552 shares of the basic materials company’s stock worth $14,923,000 after acquiring an additional 706 shares during the last quarter. Toronto Dominion Bank increased its stake in Monsanto by 6.3% in the 3rd quarter. Toronto Dominion Bank now owns 1,014,313 shares of the basic materials company’s stock worth $121,519,000 after acquiring an additional 59,750 shares during the last quarter. Nikko Asset Management Americas Inc. increased its stake in Monsanto by 1.3% in the 2nd quarter. Nikko Asset Management Americas Inc. now owns 450,700 shares of the basic materials company’s stock worth $53,345,000 after acquiring an additional 5,700 shares during the last quarter. Oakbrook Investments LLC increased its stake in Monsanto by 7.4% in the 3rd quarter. Oakbrook Investments LLC now owns 20,350 shares of the basic materials company’s stock worth $2,438,000 after acquiring an additional 1,400 shares during the last quarter. Finally, Aviva PLC increased its stake in Monsanto by 1.2% in the 2nd quarter. Aviva PLC now owns 304,501 shares of the basic materials company’s stock worth $36,052,000 after acquiring an additional 3,569 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

In related news, CFO Pierre Courduroux sold 4,320 shares of the firm’s stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total transaction of $527,040.00. Following the transaction, the chief financial officer now directly owns 48,388 shares in the company, valued at approximately $5,903,336. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the transaction, the chief operating officer now owns 85,439 shares in the company, valued at $10,255,243.17. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 49,236 shares of company stock worth $5,931,934. 0.79% of the stock is owned by corporate insiders.

Monsanto Company (NYSE MON) traded up $0.26 on Monday, reaching $119.19. The company had a trading volume of 888,134 shares, compared to its average volume of 1,961,335. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12. Monsanto Company has a fifty-two week low of $103.08 and a fifty-two week high of $122.79. The company has a market cap of $52,352.99, a price-to-earnings ratio of 21.51, a price-to-earnings-growth ratio of 1.71 and a beta of 1.04.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. During the same period last year, the company earned $0.07 EPS. Monsanto’s revenue for the quarter was up 4.8% compared to the same quarter last year. equities research analysts anticipate that Monsanto Company will post 5.74 EPS for the current fiscal year.

Several equities analysts have recently commented on the company. BMO Capital Markets reiterated a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research report on Thursday, October 5th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price objective on the stock in a research report on Tuesday, August 29th. Piper Jaffray Companies set a $128.00 price objective on Monsanto and gave the company a “buy” rating in a research report on Friday, August 11th. Barclays reiterated an “equal weight” rating and set a $124.00 price objective (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Finally, Jefferies Group reiterated a “hold” rating and set a $128.00 price objective on shares of Monsanto in a research report on Friday, September 15th. Eleven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Monsanto presently has a consensus rating of “Hold” and a consensus target price of $124.61.

COPYRIGHT VIOLATION NOTICE: This article was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://www.com-unik.info/2017/12/04/nippon-life-global-investors-americas-inc-buys-9870-shares-of-monsanto-company-mon.html.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

What are top analysts saying about Monsanto Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Monsanto Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit